Life Line Screening Provides Early Disease Diagnosis and Treatment Through Ultrasound

The fastest and safest way to healthier lives involves early diseases detection. With early diagnosis comes the right treatment administration for disease. That is why Life Line Screening has established an extensive database for patients. Life Line Screening was established in 1993. Based in Texas, the organization is privately operated with the aim of offering preventive as well as wellness programs. Life Line Screening operates on the basis of community healing structures that serve adults in the United States of America.

Background

Since its establishment, the services offered by Life Line Screening have extended across the United Kingdom. In 1998, Life Line Screening has captured huge database of clients by offering its screening services to over 500,000 individuals. In addition to the huge database was an additional finger-stick test kit for blood that gauged the cholesterol of an individual. This test kit included strips for testing diabetes, inflammation as well as protein. The preventive health screenings of Life Line Screening in the United Kingdom were established in 2007.

Operation

Following the company’s success in offering early diagnosis and treatment to patients, the company expanded its operations in 2008 by incorporating atrial fibrillation screenings. In 2012, Life Line Screening extended its services to Australia. In summation, Life Line Screening is projected to have conducted more than 8 million screenings since its establishment. Annually, the company conducts approximately 1 million screenings as well as electrocardiographs. Some of the major diseases Life Line Screening is prominent for arresting at an early stage include atrial fibrillation, arterial disease as well as abdominal aortic aneurysm.

Contribution

Annually, Life Line Screening holds approximately 16,000 community events. These events are locally held and initiated towards the development of screening services that can detect early disease and diagnosis. It is evident that Life Line Screening is focused on saving lives. A testament to these claims, University of Florida has conducted several studies concerning the benefits of early disease detection through Life Line Screening. It is factual that the organization works for the good of the society. The objective of Life Line Screening is providing a platform that arrests diseases early in life. With early detection, more lives will be saved.

Life Line Screening Social Media: https://twitter.com/Life_Line

Jim Tananbaum Invests in the Creation of Healthcare Entrepreneurs

Jim Tananbaum believes that the greatest business idea is the creation of entrepreneurs. He observes that there is a shortage of business-minded individuals to venture into producing life-changing products and services. As a result, he created Foresite Capital, a private equity company that specializes in supporting budding entrepreneurs in the health sector. The company provides capital, networks as well information to make these startups profitable. More details can be found on Ideamensch.

Jim Tananbaum has founded successful businesses in his career that span nearly three decades. Some of the firms he created include GelTex Pharmaceuticals and Theravance Biopharma. He led GelTex to develop two drugs at the cost of $80 million. The drugs currently generate over $1.2 billion annually. The market capitalization of the two companies is about $3.6 billion today. As an investor, he co-founded Prospect Venture Partners II and III as well as Sierra Ventures.

Jim Tananbaum’s objective for Foresite was to harness the future of health care by recognizing innovative healthcare solutions and products and investing in them. He understands that every great innovation requires a significant amount of capital and expertise which most young entrepreneurs lack. By providing these necessities, Jim trusts that they can help actualize revolutionary scientific discoveries in healthcare. Ever since its creation, Foresite has invested in more than 77 companies among which are 10X Genomics, Aimmune Pharmaceuticals, Intarcia Therapeutics and Aerie Pharmaceuticals.

In his line of duty, Tananbaum has learned that succeeding in business requires courage to develop concepts that are against the conventional way. He believes that innovation leads to disruption instead of convention. As an investor, he recommends a thorough analysis of any planned investment before venturing. However, he advises against being discouraged from investing by the fear of losing.

As an effective leader and mentor, Jim Tananbaum believes in synergy. He has learned to invest in people who can help him actualize his ideas. He believes that with complimenting partners, it is possible to be more productive. Consequently, Foresite recently added Molly He. Ph.D., to its executive team. Molly has over 15 years’ experience e in drug development and genomics. Jim trusts she will be invaluable as the firm expands and diversifies its portfolio.

Check out his website officialjimtananbaum.com

 Visit his Facebook page

See more: https://www.forbes.com/profile/jim-tananbaum/